EUVIMEDEUVIMED entdecken
Fallbericht

Anaphylaxis due to ceftriaxone: case series and reflection on its indiscriminate use

Natalhie Acuña Ortega, Sandra N González Díaz, Rosa I Guzmán Avilán, Marcela I Villalobos Ordaz, Ana K Chávez Ruiz, Danna S Ríos González

Allergologia et Immunopathologia · 01.11.2026 · 54 (6) · 33-38

DOI: 10.15586/aei.v54i6.1534 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Allergologia et Immunopathologia, online erschienen am 01.11.2026. Verfasst von Natalhie Acuña Ortega und 5 weiteren Autor:innen. Beteiligte Einrichtung: Regional Center for Allergy and Clinical Immunology, Dr. José Eleuterio González University Hospital, Autonomous University of Nuevo León, Monterrey,…. Hauptthemen laut MEDLINE: Ceftriaxone, Anaphylaxis, Drug Hypersensitivity, Anti-Bacterial Agents. Gefördert von: The authors received no financial support for the research, authorship, and/or publication of this article..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ceftriaxone, a third-generation cephalosporin, is widely prescribed for severe infections. Although generally considered safe, it may cause immediate hypersensitivity reactions (HSR), including anaphylaxis, representing a significant clinical concern.

Objective

To describe a case series of ceftriaxone-induced hypersensitivity reactions, highlighting clinical presentation, management patterns, and implications for rational antibiotic use.

Methods

We retrospectively analyzed eight patients evaluated in our allergy department between 2023 and 2025 for immediate HSR to ceftriaxone. Demographic characteristics, clinical manifestations, reaction severity according to Brown’s classification, management, prior exposure, and skin test results were recorded. All patients underwent skin prick testing, which if negative, was followed by intradermal testing.

Results

Patients (aged 10–44 years; with five females) presented reactions ranging from urticaria to grade III anaphylaxis. Most reactions occurred outside hospital settings, increasing the risk of delayed recognition and treatment. Despite several reactions fulfilling criteria for anaphylaxis, intramuscular epinephrine was not administered systematically, with management frequently limited to antihistamines and corticosteroids. Four patients reacted after the first reported dose; previous exposure was documented or suspected in most cases. Skin testing supported an immunoglobulin E-mediated mechanism in the majority of patients, and one patient developed anaphylaxis during intradermal testing. A progressive increase in patients was observed over the study period (1 patient in 2023, 2 in 2024, and 5 patients in 2025). One patient successfully completed treatment through a standardized 12-step desensitization protocol.

Conclusions

Ceftriaxone-induced HSR could be severe and occur frequently outside controlled medical settings. Under-recognition of anaphylaxis and underuse of epinephrine remain significant concerns. Rational antibiotic prescribing, improved adherence to anaphylaxis management guidelines, and structured allergy evaluation—including desensitization if necessary—are essential to optimize patient safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftriaxoneAnaphylaxisDrug HypersensitivityAnti-Bacterial AgentsHumansFemaleAdultAdolescentChildRetrospective StudiesYoung AdultMaleSkin TestsThird Generation Cephalosporins

Stichwörter der Autor:innen

anaphylaxisceftriaxoneceftriaxone allergydesensitizationdrug allergy

Substanzen

CeftriaxoneAnti-Bacterial AgentsThird Generation Cephalosporins

Autor:innen und Institutionen

  • Regional Center for Allergy and Clinical Immunology, Dr. José Eleuterio González University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Regional Center for Allergy and Clinical Immunology, Dr. José Eleuterio González University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico; rosyguzman30@gmail.com.

Förderung

  • The authors received no financial support for the research, authorship, and/or publication of this article.

Zitieren

APA

Ortega, N. A., González Díaz, S. N., Guzmán Avilán, R. I., Villalobos Ordaz, M. I., Chávez Ruiz, A. K., & Ríos González, D. S. (2026). Anaphylaxis due to ceftriaxone: case series and reflection on its indiscriminate use. Allergologia et Immunopathologia, 54(6), 33-38. https://doi.org/10.15586/aei.v54i6.1534

Vancouver

Ortega NA, González Díaz SN, Guzmán Avilán RI, Villalobos Ordaz MI, Chávez Ruiz AK, Ríos González DS. Anaphylaxis due to ceftriaxone: case series and reflection on its indiscriminate use. Allergologia et Immunopathologia. 2026;54(6):33-38. doi:10.15586/aei.v54i6.1534

BibTeX
@article{Ortega2026,
  author = {Ortega, Natalhie Acuña and González Díaz, Sandra N and Guzmán Avilán, Rosa I and Villalobos Ordaz, Marcela I and Chávez Ruiz, Ana K and Ríos González, Danna S},
  title = {Anaphylaxis due to ceftriaxone: case series and reflection on its indiscriminate use},
  journal = {Allergologia et Immunopathologia},
  year = {2026},
  volume = {54},
  number = {6},
  pages = {33--38},
  doi = {10.15586/aei.v54i6.1534}
}
Kostenlos starten →